📣 VC round data is live. Check it out!
- Public Comps
- Sofwave Medical
Sofwave Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sofwave Medical and similar public comparables like NeuroPace, Japan Lifeline, Tactile Medical, Bioventus and more.
Sofwave Medical Overview
About Sofwave Medical
Sofwave Medical Ltd is engaged in the development, marketing, and production of non-invasive technology for skin rejuvenation and firming treatment.
Founded
N/A
HQ

Employees
N/A
Website
Financials (FY)
EV
$523M
Valuation Multiples
Start free trialSofwave Medical Financials
Sofwave Medical reported last fiscal year revenue of $88M and EBITDA of $8M.
In the same fiscal year, Sofwave Medical generated $66M in gross profit, $8M in EBITDA, and $5M in net income.
Sofwave Medical P&L
In the most recent fiscal year, Sofwave Medical reported revenue of $88M and EBITDA of $8M.
Sofwave Medical is profitable as of last fiscal year, with gross margin of 75%, EBITDA margin of 9%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Sofwave Medical Stock Performance
Sofwave Medical has current market cap of $556M, and enterprise value of $523M.
Market Cap Evolution
Sofwave Medical's stock price is $15.39.
Sofwave Medical share price decreased by 5.9% in the last 30 days, and increased by 137.7% in the last year.
Sofwave Medical has an EPS (earnings per share) of $0.15.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $523M | $556M | -3.5% | -5.9% | 24.4% | 137.7% | $0.15 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSofwave Medical Valuation Multiples
Sofwave Medical trades at 6.0x EV/Revenue multiple, and 68.7x EV/EBITDA.
Sofwave Medical Financial Valuation Multiples
As of June 4, 2026, Sofwave Medical has market cap of $556M and EV of $523M.
Sofwave Medical has a P/E ratio of 101.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sofwave Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Sofwave Medical Margins & Growth Rates
In the most recent fiscal year, Sofwave Medical reported gross margin of 75%, EBITDA margin of 9%, and net margin of 6%.
Sofwave Medical Margins
Sofwave Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Sofwave Medical Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Sofwave Medical Competitors
Sofwave Medical competitors include NeuroPace, Japan Lifeline, Tactile Medical, Bioventus, Polynovo, Beta Bionics, Cytek Biosciences, Cerus, IBA Group and MiMedx Group.
Most Sofwave Medical public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.7x | 5.7x | (114.3x) | (86.6x) | |||
| 1.4x | 1.3x | 5.8x | 5.6x | |||
| 1.4x | 1.4x | 10.6x | 10.1x | |||
| 1.4x | 1.3x | 6.8x | 6.7x | |||
| 5.9x | 5.0x | 72.0x | 57.2x | |||
| 3.8x | 3.3x | (7.1x) | (5.9x) | |||
| 1.5x | 1.5x | (463.4x) | (186.0x) | |||
| 2.4x | 2.3x | 58.8x | 40.6x | |||
This data is available for Pro users. Sign up to see all Sofwave Medical competitors and their valuation data. Start Free Trial | ||||||
Sofwave Medical VC Funding History
Before going public, Sofwave Medical raised $8M in total equity funding, across 1 round.
Sofwave Medical Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sofwave Medical
| Where is Sofwave Medical headquartered? | Sofwave Medical is headquartered in Israel. |
| Is Sofwave Medical publicly listed? | Yes, Sofwave Medical is a public company listed on Tel Aviv Stock Exchange. |
| What is the stock symbol of Sofwave Medical? | Sofwave Medical trades under SOFW ticker. |
| When did Sofwave Medical go public? | Sofwave Medical went public in 2021. |
| Who are competitors of Sofwave Medical? | Sofwave Medical main competitors include NeuroPace, Japan Lifeline, Tactile Medical, Bioventus, Polynovo, Beta Bionics, Cytek Biosciences, Cerus, IBA Group, MiMedx Group. |
| What is the current market cap of Sofwave Medical? | Sofwave Medical's current market cap is $556M. |
| What is the current revenue of Sofwave Medical? | Sofwave Medical's last fiscal year revenue is $88M. |
| What is the current EV/Revenue multiple of Sofwave Medical? | Current revenue multiple of Sofwave Medical is 6.0x. |
| Is Sofwave Medical profitable? | No, Sofwave Medical is not profitable. |
| How many companies Sofwave Medical has acquired to date? | Sofwave Medical hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Sofwave Medical has invested to date? | Sofwave Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Sofwave Medical
Lists including Sofwave Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.